Proton Beam Therapy for Localized Prostate Cancer
Part of Cancer, Kidney & urinary clinical trials.
This study tests a very short course (ultrahypofractionated) of proton beam radiation for localized prostate cancer. It aims to see if it's safe and effective with fewer treatment visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer that has not spread to other organs.
- You are well enough to be up and about (performance status 0-2).
- You have not had your prostate removed or radiation to the pelvis before.
- You do not have other active cancers (except certain skin cancers).
- You can fill out questionnaires and follow the study plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter, more intense course of radiation (hypofractionated radiotherapy) for men with localized prostate cancer that hasn't spread. It aims to see if this treatment is safe and effective and may reduce the number of hospital visits.
This trial tests proton radiation therapy for people with high-risk prostate cancer. It may help by delivering radiation in a more targeted way, with the goal of controlling the cancer while reducing exposure to nearby healthy tissue.
This trial tests a short course of high-dose radiation therapy (radiosurgery) for prostate cancer that hasn't spread. It aims to treat the cancer with fewer sessions while keeping side effects low.
This trial tests if giving proton radiation in just two sessions, guided by MRI, is safe and effective for low- or intermediate-risk prostate cancer. It may mean fewer trips to the hospital for treatment.
This trial tests radiation therapy for men with very high-risk prostate cancer that hasn't spread. It aims to see if targeting the tumor with radiation can help control the cancer in this highest risk group.
This trial uses a special type of radiation called carbon ion therapy given in just 4 sessions (ultra-hypofractionated) to treat prostate cancer. It aims to see if this short treatment is safe and effective for men with low or intermediate risk prostate cancer.
Hear when a new Prostate Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.